Liver targeting of plasmid DNA with a cationized pullulan for tumor suppression

Journal of Nanoscience and Nanotechnology

Volumn 6, Issue 9-10, 2006, Pages 2853-2859

  Jo, Jun Ichiro ^a   Yamamoto, Masaya ^a,b   Matsumoto, Kunio ^c   Nakamura, Toshikazu ^c   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Liver Targeting; Plasmid DNA; Tumor Suppression

Indexed keywords

LIVER TARGETING; PLASMID DNA; TUMOR SUPPRESSION;

COMPLEXATION; GENES; MOLECULAR WEIGHT; POLYSACCHARIDES; TUMORS;

DNA;

CATION; DRUG VEHICLE; GLUCAN; NANOMATERIAL; PULLULAN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CHEMISTRY; DRUG DELIVERY SYSTEM; EVALUATION; FEMALE; GENE TARGETING; GENE THERAPY; GENETICS; LIVER TUMOR; LYMPHOMA; METHODOLOGY; MOUSE; PATHOLOGY; PLASMID; TREATMENT OUTCOME; VEHICLES;

ANIMALS; CATIONS; DRUG DELIVERY SYSTEMS; FEMALE; GENE TARGETING; GENE THERAPY; GLUCANS; LIVER NEOPLASMS; LYMPHOMA; MICE; MICE, INBRED BALB C; NANOSTRUCTURES; PLASMIDS; TREATMENT OUTCOME; VEHICLES;

EID: 33750043210     PISSN: 15334880     EISSN: None     Source Type: Journal    
DOI: 10.1166/jnn.2006.466     Document Type: Conference Paper

References (54)

1. G. Emilien, M. Ponchon, C. Caldas, O. Isacson, and J. M. Maloteaux, Qjm. 93, 391 (2000).
2. Q. Wu, T. Moyana, and J. Xiang, Curr. Gene Ther. 1, 101 (2001).
3. T. Merdan, J. Kopecek, and T. Kissel, Adv. Drug Deliv. Rev. 54, 715 (2002).
4. M. Matsuura, Y. Yamazaki, M. Sugiyama, M. Kondo, H. Ori, M. Nango, and N. Oku, Biochim. Biophys. Acta. 1612, 136 (2003).
5. K. Kawabata, Y. Takakura, and M. Hashida, Pharm. Res. 12, 825 (1995).
6. D. Lew, S. E. Parker, T. Latimer, A. M. Abai, A. Kuwahara-Rundell, S. G. Doh, Z. Y. Yang, D. Laface, S. H. Gromkowski, and G. J. Nabel et al., Hum. Gene Ther. 6, 553 (1995).
7. L. Yu, H. Suh, J. J. Koh, and S. W. Kim, Pharm. Res. 18, 1277 (2001).
8. M. Grossman, S. E. Raper, K. Kozarsky, E. A. Stein, J. F. Engelhardt, D. Muller, P. J. Lupien, and J. M. Wilson, Nat. Genet. 6, 335 (1994).
9. T. Hara, Y. Tan, and L. Huang, Proc. Natl. Acad. Sci. USA 94, 14547 (1997).
10. J. M. Wilson, Nat Genet. 12, 232 (1996).
11. M. Nishikawa, M. Yamauchi, K. Morimoto, E. Ishida, Y. Takakura, and M. Hashida, Gene Ther. 7, 548 (2000).
12. J. C. Perales, G. A. Grossmann, M. Molas, G. Liu, T. Ferkol, J. Harpst, H. Oda, and R. W. Hanson, J. Biol. Chem. 272, 7398 (1997).
13. M. Nishikawa, S. Takemura, Y. Takakura, and M. Hashida, J. Pharmacol. Exp. Ther. 287, 408 (1998).
14. M. Hashida, S. Takemura, M. Nishikawa, and Y. Takakura, J. Control. Rel. 53, 301 (1998).
15. G. Y. Wuand and C. H. Wu, J. Biol. Chem. 263, 14621 (1988).
16. Y. Kaneo, T. Tanaka, T. Nakano, and Y. Yamaguchi, J. Control. Rel. 70, 365 (2001).
17. T. Yamaoka, Y. Tabata, and Y. Ikada, J. Pharm. Pharmacol. 47, 479 (1995).
18. T. Yamaoka, Y. Tabata, and Y. Ikada, Drug Delivery I (1993).
19. K. Xi, Y. Tabata, K. Uno, M. Yoshimoto, T. Kishida, Y. Sokawa, and Y. Ikada, Pharm. Res. 13, 1846 (1996).
20. H. Hosseinkhani, T. Aoyama, O. Ogawa, and Y. Tabata, J. Control. Rel. 83, 287 (2002).
21. T. Nakamura, T. Nishizawa, M. Hagiya, T. Seki, M. Shimonishi, A. Sugimura, K. Tashiro, and S. Shimizu, Nature 342, 440 (1989).
22. R. Zarnegarand and G. K. Michalopoulos, J. Cell. Biol. 129, 1177 (1995).
23. K. Matsumotoand and T. Nakamura, Biochem. Biophys. Res. Commun. 239, 639 (1997).
24. C. Birchmeierand amd E. Gherardi, Trends Cell Biol. 8, 404 (1998).
25. J. Cortner, G. F. Vande Woude, and S. Rong, Exs. 74, 89 (1995).
26. E. M. Rosenand and I. D. Goldberg, Adv. Cancer Res. 67, 257 (1995).
27. M. Jeffers, S. Rong, and G. F. Woude, J. Mol. Med. 74, 505 (1996).
28. C. T. Toand and M. S. Tsao, Oncol. Rep. 5, 1013 (1998).
29. W. Jiang, S. Hiscox, K. Matsumoto, and T. Nakamura, Crit. Rev. Oncol. Hematol. 29, 209 (1999).
30. K. Date, K. Matsumoto, H. Shimura, M. Tanaka, and T. Nakamura, FEBS Lett. 420, 1 (1997).
31. K. Date, K. Matsumoto, K. Kuba, H. Shimura, M. Tanaka, and T. Nakamura, Oncogene. 17, 3045 (1998).
32. K. Kuba, K. Matsumoto, K. Date, H. Shimura, M. Tanaka, and T. Nakamura, Cancer Res. 60, 6737 (2000).
33. D. Tomioka, N. Maehara, K. Kuba, K. Mizumoto, M. Tanaka, K. Matsumoto, and T. Nakamura, Cancer Res. 61, 7518 (2001).
34. Y. Saga, H. Mizukami, M. Suzuki, M. Urabe, A. Kume, T. Nakamura, I. Sato, and K. Ozawa, Gene Ther. 8, 1450 (2001).
35. N. Maehara, E. Nagai, K. Mizumoto, N. Sato, K. Matsumoto, T. Nakamura, K. Narumi, T. Nukiwa, and M. Tanaka, Clin. Exp. Metastasis. 19, 417 (2002).
36. S. Hirao, Y. Yamada, F. Koyama, H. Fujimoto, Y. Takahama, M. Ueno, K. Kamada, T. Mizuno, M. Maemondo, T. Nukiwa, K. Matsumoto, T. Nakamura, and Y. Nakajima, Cancer Gene Ther. 9, 700 (2002).
37. M. Saimura, E. Nagai, K. Mizumoto, N. Maehara, H. Okino, M. Katano, K. Matsumoto, T. Nakamura, K. Narumi, T. Nukiwa, and M. Tanaka, Cancer Gene Ther. 9, 799 (2002).
38. M. Maemondo, K. Narumi, Y. Saijo, K. Usui, M. Tahara, R. Tazawa, K. Hagiwara, K. Matsumoto, T. Nakamura, and T. Nukiwa, Mol. Ther. 5, 177 (2002).
39. G. T. Hermanson, Bioconjugate Techniques, Academic Press, California (1996), p. 137.
40. M. Tokui, I. Takei, F. Tashiro, A. Shimada, A. Kasuga, M. Ishii, T. Ishii, K. Takatsu, T. Saruta, and J. Miyazaki, Biochem. Biophys. Res. Commun. 233, 527 (1997).
41. Y. Tabata, T. Ishii, T. Aoyama, R. Oki, Y. Hirano, O. Ogawa, and Y. Ikada, Prospectives of Fullerene Nanotechnology, Kluwer Academic Publishers, London (2002), p. 185.
42. P. M. Mullen, C. P. Lollo, Q. C. Phan, A. Amini, M. G. Banaszczyk, J. M. Fabrycki, D. Wu, A. T. Carlo, P. Pezzoli, C. C. Coffin, and D. J. Carlo, Biochim. Biophys. Acta. 1523, 103 (2000).
43. I. Moret, J. Esteban Peris, V. M. Guillem, M. Benet, F. Revert, F. Dasi, A. Crespo, and S. F. Alino, J. Control. Rel. 76, 169 (2001).
44. S. Parkand and K. E. Healy, Bioconjug Chem. 14, 311 (2003).
45. H. Hosseinkhani, T. Aoyama, S. Yamamoto, O. Ogawa, and Y. Tabata, Pharm. Res. 19, 1471 (2002).
46. N. K. Egilmez, Y. Iwanuma, and R. B. Bankert, Biochem. Biophys. Res. Commun. 221, 169 (1996).
47. M. Nishikawaand and L. Huang, Hum. Gene Ther. 12, 861 (2001).
48. C. W. Poutonand and L. W. Seymour, Adv. Drug Deliv. Rev. 46, 187 (2001).
49. V. P. Torchilin, J. Mol. Recognit. 9, 335 (1996).
50. B. K. Sim, N. J. MacDonald, and E. R. Gubish, Cancer Metastasis Rev. 19, 181 (2000).
51. H. L. Kongand and R. G. Crystal, J. Natl. Cancer Inst. 90, 273 (1998).
52. J. M. Pluda, Semin Oncol. 24, 203 (1997).
53. A. Mancusoand and C. N. Stemberg, Crit. Rev. Oncol. Hematol. 55, 67 (2005).
54. K. Kuba, K. Matsumoto, K. Ohnishi, T. Shiratsuchi, M. Tanaka, and T. Nakamura, Biochem. Biophys. Res. Commun. 279, 846 (2000).